Lori A Woods
CIK 1393007 · CEO · last filed 2026-03-04
Lori A Woods is a CEO who has filed 29 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing, for CATX, was dated Mar 4, 2026. Across all open-market trades the lifetime net is +$421.8K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $421.7K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
ISR price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
SUITE 106
RICHLAND, WA 99354
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CATX | Director | 188,267 | $2.24 | $421.7K | $200.0K | 11 | 2026-03-04 |
| Perspective Therapeutics, Inc. (ISR) Delisted | CEO | 1,195,114 | $0.38 | $458.9K | $221.8K | 18 | 2022-11-17 |
Recent Filings
29 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-04 | CATX | Grant (A) | — | $0 | EDGAR |
| 2025-04-01 | CATX | Buy (P) | +23,475 | $50.0K | EDGAR |
| 2025-03-05 | CATX | Grant (A) | — | $0 | EDGAR |
| 2024-06-24 | CATX | Grant (A) | — | $0 | EDGAR |
| 2024-06-18 | CATX | Buy (P) | +4,587 | $50.0K | EDGAR |
| 2024-06-05 | CATX | — | — | $0 | EDGAR |
| 2024-06-04 | CATX | Buy (P) | +34,246 | $50.0K | EDGAR |
| 2023-12-18 | CATX | Buy (P) | +185,200 | $50.0K | EDGAR |
| 2023-12-14 | CATX | Grant (A) | — | $0 | EDGAR |
| 2023-04-19 | CATX | Exer (M) | +187,500 | $114.4K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.